FDA Revokes Hydroxychloroquine’s Emergency Use Status for COVID-19

    0
    99

    The U.S. Food and Drug Administration on Monday revoked the emergency use authorization for malaria drug hydroxychloroquine as a treatment for COVID-19, the use of which has been championed by U.S. President Donald Trump.

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here